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Abstract: Several viral infections of swine are responsible for major economic losses and represent
a threat to the swine industry worldwide. New tools are needed to prevent and control endemic,
emerging, and re-emerging viral diseases. Dendritic cells (DC) play a central role in linking the innate
and adaptive arms of the immune system, so knowledge regarding their interaction with pathogens
is necessary to understand the mechanisms underlying diseases pathogenesis and protection. In the
first part of this review, we provide an update on the heterogeneous cell subsets that comprise the
porcine DC family. In the second part of this review, we provide an overview of how three viruses,
affecting pork production at a global level, African swine fever virus (ASFV), classical swine fever
virus (CSFV), and porcine circovirus 2 (PCV2), modulate DC function.
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1. Introduction
Pork production accounts for more than one-third of all meat production worldwide, and
infectious diseases are its primary constraint. Globalisation and industrialisation of the pig industry
has contributed to the emergence and spread of pathogens, including viruses [1]. A recent study,
which used published research as an indicator of research priorities, revealed that the most important
swine viruses worldwide between 2006–2016 were: swine influenza virus (SwIV), pseudorabies virus
(PRV), foot-and-mouth disease virus (FMDV), porcine reproductive and respiratory syndrome virus
(PRRSV), classical swine fever virus (CSFV), African swine fever virus (ASFV), and porcine circovirus 2
(PCV2) [1]. The top published virus worldwide was the zoonotic SwIV, and four of the other top
published viruses (PRV, FMDV, ASFV, and CSFV) cause diseases listed as notifiable by the OIE World
Organization for Animal Health. PRRSV and PCV2 are not notifiable pathogens, as they are endemic
in the majority of pig producing countries and they compromise pork production by their effect on
mortality, reproduction, and growth [1]. New tools are needed to aid in preventing the spread of
devastating epizootic viruses and reducing the incidence of the endemic ones. Vaccines play a critical
role in preventing, managing, and controlling viral diseases. In order to rationally design vaccines, it is
mandatory to acquire information regarding both humoral and cellular immune responses against
pathogens [2]. Dendritic cells (DC) are the most potent antigen-presenting cells (APCs) and, as such,
link the innate and adaptive arms of the immune system [3]. A better understanding of how these
cells interact with pathogens is of major importance to comprehend both diseases pathogenesis and
mechanisms behind immunological protection, generating important information that underpins
vaccine research and development efforts. Therefore, in the first part of this article, we provide an
update on our understanding of porcine DC, which has benefitted from a number of recent studies
that phenotypically and functionally characterised both blood-borne and tissue-resident DC subsets.
Since DC interactions with SwIV, PRRSV, and FMDV were recently reviewed in detail [4,5], we discusse,
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in the second part of this review, DC interaction with three other viruses that threaten the swine
industry: ASFV, CSFV, and PCV2.
2. Dendritic Cells
2.1. Dendritic Cells: A Heterogeneous Family
DC are a class of bone marrow-derived cells that were originally identified by Steinman and
Cohn in the early 1970s [6]. They are regarded as professional APCs and are considered to be the
sentinels of the immune system [3]. To execute their role as sentinels, they are equipped with several
pattern recognition receptor (PRRs), which recognize pathogen-associated molecular patterns (PAMPs)
and can detect foreign antigen at the entry sites, such as skin and mucosae [7]. They can uptake
and process proteins, and then migrate into the secondary lymphoid tissues to present the processed
antigens to lymphocytes [3]. In most tissues, DC reside in an immature state. Immature DC lack
co-stimulatory molecules that are required for naïve T cells activation, such as CD40, CD54, and
CD80/86, and the majority of major histocompatibility complex (MHC) class II molecules are located
within the intracellular compartment [8]. On the contrary, mature DC are characterized by reduced
endocytic/phagocytic activity and, instead, present accessory molecules and the extracellular expression
of MHC class II [8,9]. DC present the unique ability of priming naïve T lymphocytes and possess a key
role in controlling T lymphocyte activation and regulation [8]. DC also have important roles in B-cell
activation and the regulation of antibody synthesis, producing factors that are important for their
proliferation, differentiation, and isotype switching [8]. They can also directly interact with B cells,
directly transferring antigens to naïve B cells to initiate specific antibody synthesis [10]. In addition,
DC are involved in natural killer (NK) cell activation by releasing both IL-12, which increases NK
cytotoxicity, and IL-15, which has a critical role in NK cell survival, expansion, and function [11,12].
The cross-talk between NK cells and DCs is bidirectional, and activated NK cells can further mature
DC, which enhances their ability to stimulate T cell responses [13]. DC also play a role in γδ-T cell
activation, through the release of pro-inflammatory cytokines and expression of ligands for γδ TcR and
natural killer receptors (NKRs) [14].
DCs are a heterogeneous family, being broadly subdivided in three major subsets: conventional
DC1 (cDC1), conventional DC2 (cDC2), and plasmacytoid DC (pDC) [15]. As recently reviewed by
Collin and Bigley (2018), cDC1 present high capacity to promote CD4+ T helper 1 (TH1) and NK
responses, through IL-12 secretion, and to cross-present exogenous antigen via MHC class I to CD8+
T cells, whereas cDC2 promote CD4+ T helper 2 (TH2) and 17 (TH17) responses [15]. In contrast to
mice, in humans, cross-presentation to CD8+ T cells is performed by both cDC1 and cDC2 [15]. pDC
were first identified in human as CD4+CD3− cells with a plasma cell-like morphology and they were
initially erroneously considered to be cells of the lymphoid lineage [16]. These cells selectively express
Toll-like receptor TLR-7 and TLR-9 and they are specialized in secreting large amounts of type I IFN
following viral stimulation [17].
The heterogeneity of DCs from different organs is also remarkable. In humans, Granot et al. (2017)
observed that cDC subsets from mucosal sites (lung and intestines) presented different composition
and higher cDC2/cDC1 ratios when compared to lymph nodes and demonstrated that cDC subsets
distribution was mainly a function of the specific tissue [18]. The authors observed that cDC2
presented higher maturation and migration properties as compared to cDC1, and mature cDC2 in
mucosal-draining lymph nodes expressed tissue-specific markers that were derived from their original
mucosal site [18]. These results revealed tissue-specific DC maturation, associated with migration
phenotypes [18].
Summerfield and McCullough firstly reviewed porcine DC in 2009 [19]. Each species has its own
peculiarities, so, in this article, we provide an update on the phenotype and functions of porcine DC
subsets in the blood and different organs.
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2.2. Porcine Blood DC
In 2003, Summerfield et al. provided the first characterization of blood DC subsets and identified
CD172a+CD14−CD4− cells that resembled human cDC, and CD172a+CD14−CD4+ cells orthologous
to human pDC, which represented 0.2–0.6% and 0.1–0.3% of peripheral blood mononuclear cells
(PBMC), respectively [20]. Porcine blood cDC presented an MHC II+CD80/86+CD1+/−CD4−CD14−
phenotype and up-regulated both MHC II and CD80/86 after a short culture period (24 hours) with
granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-3. Blood pDC
instead presented a CD4+MHC IIlowCD80/86lowCD1-CD8−/lowCD16−/lowCD45RA−/low phenotype and
had a high IL-3 binding capacity. This cytokine promoted pDC survival in vitro [20]. As expected,
pDC produced high levels of type I IFN after stimulation with transmissible gastroenteritis virus
(TGEV). Both freshly isolated DC subsets presented high endocytic activity, which decreased after
in vitro culture [20]. In 2016, Summerfield’s group provided a further characterization of blood
DC subsets, through multicolour flow cytometry, cell sorting, and RNA sequencing [21]. pDC
presented a CD4+CD135+CD172a+CD123+CD303+ phenotype and selectively expressed TCF4 and
NRP1. Unlike in humans and mice, porcine pDC presented a high expression of complement-related
genes (C2, C3, C5, and CD93), which suggests a prominent role of these cells in complement biology
when compared to other species. As expected, porcine pDC expressed the highest levels of TLR-7
and TLR-9 expression, but, unlike human and mice, this subset also expressed the highest levels
of TLR-3 [21]. The porcine equivalent of cDC1 and cDC2 were identified and characterized: cDC1
were CD135+CD14−CD172alowCADM1+wCD11R1+ and expressed BATF3 and XCR1, whereas cDC2
presented a CD135+CD14−CD172a+CADM1+CD115+wCD11R1+CD1+ phenotype and expressed
FCER1A and FCGR2B [21]. In pigs, cDC1 presented relatively high levels of TLR-9, which resembled
mice but not human cDC1 [21]. The responses to TLR ligands were also assessed and porcine pDC
were the most important source of TNF-α, IL-12p40, and IFN-α. In pigs, it appears that pDC are an
important source of IL-12, whereas both cDC subsets were unable to produce this cytokine following
in vitro stimulation. TLR stimulation upregulated the surface expression of MHC II and co-stimulatory
molecules on cDC, and this was enhanced by the presence of pDC, especially for TLR-7 and TLR-9
ligands [21]. A recent study also focused on porcine blood cDC characterization, which were segregated
in two different subsets by their expression of CD1 [22]. The authors observed that CD1− cDC secreted
IFN-α, IL-12, and TNF-α following TLR stimulation and presented a superior ability to cross-present
viral antigen to CD8 T cells, thus resembling human cDC1. On the contrary, CD1+ cDC, which
expressed higher levels of CD172a, MHC II, and CD11b when compared to the other cDC subset,
produced greater amounts of IL-8 and IL-10 after LPS stimulation, suggesting that they resemble more
human cDC2, involved in promoting a TH2 response [22]. Figure 1 summarizes the phenotypical and
functional descriptions of pig blood DC subsets.
The blood DC subsets in newborn piglets were also recently studied. It was reported that neonatal
pigs (four-day-old) had similar DC subset proportions within the total PBMC population as compared
to immunocompetent older (12-week-old) weaned piglets, whereas the neonates presented a higher
proportion of monocytes [23]. Neonatal cDC1 expressed higher levels of MHC II, instead no differences
in CD80/86 levels on DC subsets were detected between the new-born and older piglets [23]. Pam3Cys
(TLR-2 ligand) induced a stronger TNF-α expression in pDC and a higher CD80/86 up-regulation in
cDC1 in new-borns when compared to older piglets. Furthermore, CpG oligodeoxynucleotide (ODN)
(TLR-9 ligand) induced a higher IL-12p40 expression in neonatal pDC. Those differences were not
linked to variation in TLR-2 and TLR-9 expression, which were similar between the neonatal and
older piglet CD3-depleted PBMC at steady-state [23]. In another study, the responses of neonatal
blood derived DC to poly(I:C) (TLR-3 ligand), LPS (TLR-4 ligand), and imiquimod (TLR-7 ligand)
were assessed [24]. Neonatal blood DC showed significant increases in CD80/86 expression that was
similar to blood DC that was isolated from older (eight-week-old) piglets. TLR-7 stimulation induced
significantly higher expression of several chemokines (CCL2, CCL3, CCL10, and CXCL8) by neonatal
blood DC when compared to their older piglet counterparts. In addition, the stimulation of these cells
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with TLR-7 ligand induced higher levels of IL-12 as compared to older animals. Interestingly, despite
equal proportions of pDC, neonatal but not older piglet blood DC produced IFN-α after TLR7 or TLR3
ligand stimulation. In addition, neonatal blood DC displayed a greater ability to induce lymphocyte
proliferation in the mixed leucocyte reaction (MLR) assay [24]. These studies suggest that TLR-2,
TLR-3, TLR-7, and TLR-9 ligands could be promising candidates for neonatal adjuvant application,
although further studies on DC isolated from neonatal lymphoid tissues are required [23,24].
Viruses 2019, 11, x FOR PEER REVIEW 3 of 16 
 
In 2003, Summerfield et al. provided the first characterization of blood DC subsets and identified 
CD172a+CD14−CD4− cells that resembled human cDC, and CD172a+CD14−CD4+ cells orthologous to 
human pDC, which represented 0.2–0.6% and 0.1–0.3% of peripheral blood mononuclear cells 
(PBMC), respectively [20]. Porcine blood cDC presented an MHC II+CD80/86+CD1+/−CD4−CD14− 
phenotype and up-regulated both MHC II and CD80/86 after a short culture period (24 hours) with 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-3. Blood pDC 
instead presented a CD4+MHC IIlowCD80/86lowCD1-CD8−/lowCD16−/lowCD45RA−/low phenotype and had 
a high IL-3 binding capacity. This cytokine promoted pDC survival in vitro [20]. As expected, pDC 
produced high levels of type I IFN after stimulation with transmissible gastroenteritis virus (TGEV). 
Both freshly isolated DC subsets presented high endocytic activity, which decreased after in vitro 
culture [20]. In 2016, Summerfield’s group provided a further characterization of blood DC subsets, 
through multicolour flow cytometry, cell sorting, and RNA sequencing [21]. pDC presented a 
CD4+CD135+CD172a+CD123+CD303+ phenotype and selectively expressed TCF4 and NRP1. Unlike in 
humans and mice, porcine pDC presented a high expression of complement-related genes (C2, C3, 
C5, and CD93), which suggests a prominent role of these cells in complement biology when compared 
to other species. As expected, porcine pDC expressed the highest levels of TLR-7 and TLR-9 
expression, but, unlike human and mice, this subset also expressed the highest levels of TLR-3 [21]. 
The porcine equivalent of cDC1 and cDC2 were identified and characterized: cDC1 were 
CD135+CD14-CD172alowCADM1+wCD11R1+ and expressed BATF3 and XCR1, whereas cDC2 
presented a CD135+CD14−CD172a+CADM1+CD115+wCD11R1+CD1+ phenotype and expressed 
FCER1A and FCGR2B [21]. In pigs, cDC1 presented relatively high levels of TLR-9, which resembled 
mice but not human cDC1 [21]. The responses to TLR ligands were also assessed and porcine pDC 
were the most important source of TNF-α, IL-12p40, and IFN-α. In pigs, it appears that pDC are an 
important source of IL-12, whereas both cDC subsets were unable to produce this cytokine following 
in vitro stimulation. TLR stimulation upregulated the surface expression of MHC II and co-
stimulatory molecules on cDC, and this was enhanced by the presence of pDC, especially for TLR-7 
and TLR-9 ligands [21]. A recent study also focused on porcine blood cDC characterization, which 
were segregated in two different subsets by their expression of CD1 [22]. The authors observed that 
CD1− cDC ecreted IFN-α, IL-12, and TNF-α following TLR stimulation and presented a superior 
ability to cross-present viral antigen to CD8 T cells, thus resembling human cDC1. On the contrary, 
CD1+ cDC, which expressed higher levels of CD172a, MHC II, and CD11b when compared to the 
other cDC subset, produced greater amounts of IL-8 and IL-10 after LPS stimulation, suggesting that 
they resemble more human cDC2, involved in promoting a TH2 response [22]. Figure 1 summarizes 
the phenotypical and functional descriptions of pig blood DC subsets. 
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the figures.
2.3. Monocyte-Derived DC
Due to the low frequency of DC in blood and tissues, cDC can be generated in vitro by culturing
monocytes in medium that is supplemented with recombinant GM-CSF and IL-4 [25,26]. These
monocyte-derived DCs (MoDC) present a dendritic morphology, a MHCIIhighCD80/86+CD172a+CD1+
phenotype, and a strong T-cell stimulatory capacity [25,26]. Interestingly, CD163+ monocytes presented
a higher ability to differentiate to moDC (higher levels of MHC II and CD80/86 and more efficient
in promoting lymphoproliferation) as compared to CD163− monocytes [27]. The differentiation of
porcine MoDC may also be achieved through the use of IL-13 instead of IL-4 [28].
moDC generated through IL-4/IL-13 and GM-CSF incubation are in an immature state and
present a high endocytic activity and lower expression of MHC II and co-stimulatory molecules when
compared to their mature counterparts [8,19]. The maturation of porcine moDC can be achieved
through IFN-α and TNF-α stimulation, which results in increased MHC and CD80/86 expression [29].
Other maturation stimuli have been tested; for example, Singleton et al. (2016) matured moDC through
24 hours incubation with LPS, IFN-γ, TNF-α, IL-6, IL-1β, and prostaglandin E. Maturation with this
cocktail resulted in no morphological changes, although moDC were less adherent and presented a
higher expression of CD80/86 and CD83 and lower levels of CD14 [30].
A comparison between moDC (generated through incubation with IL-4 and GM-CSF) and blood
DC (a mixed pDC-cDC population) was performed [31]. Both of the populations were able to
uptake foreign antigens, but blood DC activity was lower than moDC. In response to LPS stimulation,
both populations upregulated CD80/86 and increased CCR7 gene expression. Both cell types stimulated
primed T-cell proliferation to the same extent, whereas moDC induced a stronger proliferation of naïve
T cells [31].
2.4. Porcine Skin DC
The skin provides an effective barrier against wide range of pathogens and environmental
challenges, and the network of skin-associated immune cells, also called the skin immune system
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(SIS), ensures the protective function of this organ [32]. The immunology of this organ in pigs was
reviewed in 2015 [32]. Swine skin is regarded as the best structural model for human skin and it
has been used to test new vaccination devices [33,34]. It is essential to characterise the skin-resident
immune populations in this species, especially resident DC, in order to understand its response to
invading pathogens and to predict the outcome of intradermal vaccination.
In the past, porcine skin DC were segregated in four subpopulations: Langerhans cells (LC),
CD172a− dermal DC, CD163+ dermal DC, and CD163low dermal DC [35]. LC reside in the basal
epidermis (the avascular superficial layer of the skin) and, unlike the other DC subsets, they originate
from embryonic precursors, mainly foetal liver monocytes, which are recruited to the epidermis during
embryonic development. They are capable of local self-renewal, but, in case of severe inflammation,
LC can be generated from monocytes and other uncharacterised myeloid precursors [15,32]. LC are
involved in maintaining epidermal health and tolerance to commensal microorganisms; nevertheless,
they are able to respond to viruses and other intracellular pathogens [15]. Porcine LC express
langerin (CD207) and represent more than 50% of skin DC [36]. They were also described as
CD172a+CD163−CD16−CADM1+CD207+MHCII+ [35].
Three DC subsets have been observed in the dermis, being discriminated by their expression of
CD172a and CD163. All of these subsets were also detected in skin-draining pseudo-afferent lymph,
which suggests that they are able to migrate from the skin to local lymph nodes [35]. CD172a− dermal
DC are efficient in cross-presenting antigen to CD8+ T cells and they resemble CD172a−CD103+ murine
dermal cDC1 [35]. CD172a+CD163low dermal DC instead resemble human CD1a+ dermal cDC2 and
promote CD4+ T differentiation into TH17 [34]. CD172+CD163+ dermal DC are accumulated in inflamed
skin and they migrate in lymph upon inflammation, resembling human CD14+monocyte-derived
dermal DC [34]. CD172+CD163+ cells also expressed CD206 and CD209 and another study reported
that CD209+ DC in the dermis are likely of monocytic origin, like in human skin [32]. The presence of
pDC in the skin was never directly described, but they were detected in the pseudo-afferent lymph
that drains the skin under steady-state conditions, which suggests their presence in the skin. pDC are
also one of the first populations to infiltrate the skin during inflammation [32]. Figure 2 summarizes
the phenotypical and functional descriptions of porcine skin DC subsets.
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2.5. Porcine DC in Tonsils and Lymph Nodes
In 2006, Jamin and colleagues first characterised porcine DCs in these organs. They defined two
populations: CD172a+CD11R1+CD1+/−CD80/86+/− and CD172a+CD4+CD1+/−CD80/86+/− DCs, which
correspond to cDC and pDC, respectively [37]. In 2018, Soldevila et al. characterised five myeloid
cells population resident in porcine tonsils, of which three were DC subsets. pDC were CD4+ and
were defined by expression of E2-2 and IRF-7 markers, cDC1 expressed CADM1highCD172alow and
high levels of XCR1, whereas cDC2 were CADM1low and expressed FLT3, IRF4, and CSF1R [38]. pDC
presented relatively low capacity for stimulating allogeneic T cells in an MLR assay, whereas the two
cDC subsets were able to stimulate both the CD4+ and CD8+ T cells, with little differences between
the subsets. cDC2 showed the highest stimulatory capacity for naïve CD4+ T cells and cDC1 were
slightly more effective in stimulating CD8+ T cell proliferation. The authors speculated that the similar
capacity of the two cDC subsets to activate CD8 T cells might be advantageous in the tonsils, being
one of the major sites of pathogen entry [38]. Another study characterising the secondary lymphoid
tissue-derived DC identified cDC as CD3−CD21−CD163−MHC IIhighCADM1high cells, further divided
in two subsets that are based on CD172 expression. cDC1, with low/no levels of CD172a, also expressed
XCR1, whereas, CD172ahigh cDC2 expressed FCeR1α [39]. Like in humans, DEC205, a receptor that
promotes antigen presentation, was differentially expressed on porcine tonsil and lymphoid tissue
cDC independently of cDC1 and 2 subsets. This is in contrast with blood, where all cDC expressed this
marker [21,39]. Figure 3 summarizes the phenotypical and functional descriptions of porcine tonsil DC.
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2.6. Porcine Respiratory DC
Three DC subsets have been identified in the porcine lung: cDC1, cDC2, and inflammatory
moDC [40]. All of th subsets pr sent d migratory ca acity and the ability to stimulate naïve T cells.
cDC1 stimulated TH1 responses, whereas cDC2 promoted TH2 response. The latter subset expressed
FCeR1α and langerin and were localized in or next t the tracheal and bronchial epithelia [40]. FCeR1α
was absent in moDC, which presented with low levels of CD163. moDC increased in the lung during
influenza A virus infection, and secreted IL-1β and IL-8 when stimulated with LPS and poly(I:C),
s g esting their pathological role during influenza [40]. The study of lu g DC is challenging,
thus in several species bronchoalveolar lavage (BAL), which is an easy non-traumatic procedure,
is used to study myeloid populations’ resident in the respiratory tract. A comparison between BAL
macrophages/DC and their interstitial counterpart in pigs was recently performed [41]. As expected,
Viruses 2019, 11, 445 7 of 17
there was a prevalence of alveolar macrophages in the BAL, but rare DC were identified and they were
highly similar to their interstitial counterpart. The results validated the study of BAL DC as a surrogate
of their parenchymal counterpart in pigs [41]. Interestingly, differences between respiratory DC in
two pig breeds (Pietrain and Duroc) were observed. Lung DC were infected in vitro with PRRSV and
their responses to infection were investigated using RNA-sequencing. The virus replicated differently
in lung DCs from the two breeds and Duroc lung DCs reacted more strongly to PRRSV infection.
The data suggested that this more efficient response was linked to IL-1β up-regulation. Overall, the
data regarding DC-virus interaction underlined the important role of genetics in pig responses to
PRRSV [42]. Figure 4 summarizes the phenotypical and functional descriptions of pig respiratory
DC subsets.
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3. Dendritic Cells and Viruses
3.1. DC and ASFV
African swine fever (ASF) is a contagious viral disease of domestic pigs and wild boars.
Its aetiological agent is the African swine fever virus (ASFV), a large, enveloped DNA virus [43];
virulent isolates cause acute haemorrhagic fever in domestic pigs, which usually die in less than
two weeks post-infection [44]. There is no licensed vaccine or treatment available, and thus ASF is
currently considered to be one of the most devastating viral disease of domestic pigs, currently being
present in many sub-Saharan African countries, Russian Federation, Trans-Caucasus, Europe, and
Southeast Asia [45,46]. ASFV infects the immune cells of the myeloid lineage, with monocytes and
macrophages being considered its primary target cells [47]. As we recently reviewed, few studies have
analysed ASFV-DC interactions [48]. Golding et al. (2016) described that porcine PBMC enriched for
DC (by depletion of CD3+ T cells, CD14+ monocytes and CD21+ B cells) released high levels of type
I interferon in response to ASFV infection, which suggests that pDC might be the source of type I
interferon in animals undergoing acute ASF [49]. Nevertheless, using a mixed DC population, the
authors could not exclude that cDC released type I IFN following infection [49]. Instead, our group
conducted an in vitro study that was focussed on the interaction of porcine moDC with ASFV strains
of diverse virulence [50]. All of the tested ASFV strains (BA71V, NH/P68, 22653/14) infected moDC,
which supported productive virus replication, although the culture-adapted BA71V strain replicated
less efficiently than the other two strains. Infection with attenuated (BA71V and NH/P68) but not
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virulent (22653/14) ASFV resulted in MHC I down-regulation on moDC [50], which, in vivo, might
affect NK cell activation [51], which has been positively correlated to survival after ASFV infection [52].
None of the ASFV strains tested induced a strong cytokine response from immature or IFN-α/TNF-α
matured moDC: no detectable release of IFN-β, IL-1β, IL-6, IL-8, IL-10, IL-12, IL-18, and TNF-α was
observed following ASFV infection [50]. In addition, it was recently observed that moDC infection
with ASFV strains of diverse virulence resulted in a decreased phagocytic ability of these cells [53].
Overall, these results suggest that virulent ASFV isolates have evolved mechanisms to support covert
replication in cDC. More studies that are focused on ASFV-blood DC interactions are needed, which
take into consideration the heterogeneity within this family. In addition, studies that are focused on
ASFV interaction with DC from various tissues are required. In the past, it was reported that ASFV
can infect skin-derived DC [54] and interdigitating DC in mandibular lymph nodes [55], but in the
last decades, many steps forward have been taken in the characterisation of DC in different organs.
Therefore, future studies on ASFV modulation of DC phenotype and function in skin, tonsils, lymph
nodes, and other organs should consider the new knowledge of the DC ‘system’ and take advantage
of an improved toolbox for the analysis of the porcine immune system. Figure 5 summarizes the
interactions of ASFV with different DC subsets.
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3.2. DC and CSFV
Classical swine fever (CSF) is a contagious and often fatal disease of domestic pigs and wild boar
and, as mentioned before, it is classified as a notifiable disease by the OIE [56]. In the last ten years,
CSF outbreaks were detected in Eastern Europe, South East Asia, Japan, Latin America, and Russia [46].
The etiological agent is the classical swine fever virus (CSFV), a small (40–60 nm in diameter) enveloped
positive stranded RNA virus, and a member of the Pestivirus genus within the Flaviviridae family [57].
The virus has four structural proteins (core, Erns, E1, and E2) and eight non-structural proteins (Npro,
p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B) [57]. Endothelial cells, leukocytes, and some epithelial
cells, like the tonsillar crypt epithelial cells, are its major target cells in vivo [56]. In endemic regions the
disease is mainly controlled by prophylactic vaccination with live attenuated vaccines, such as C-strain,
which confer an effective, rapid, and solid immune protection. Nevertheless, these live attenuated
vaccines lack DIVA (differentiating infecting and vaccinated animals) capability, thus are not used
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in the European Union (EU) [58,59]. In the EU, the current eradication program is based on strict
stamping out strategy with restriction of movements of pig and pig products. In the light of the huge
economic damaged that is caused by CSF outbreaks, significant efforts have been made towards the
development of CSF marker vaccines [59]. In 2014, the CP7_E2alf, a chimeric virus with a bovine
virus diarrhoea virus-1 (BVDV-1) backbone containing the CSFV envelope protein, E2, was licenced
by the European Medicines Agency [59]. CSFV and BVDV-1 are considered in two different species,
presenting different host range and more than 25% differences at the genome sequence level [60].
This chimeric vaccine is innocuous and induces immunity in wild boar after oral immunization, thus it
might replace live attenuated CSF vaccines in wild boar immunisation [59].
Several studies have focused on CSFV-DC interactions in order to gain insight into the
immunomodulatory characteristics of this virus. CSFV is highly efficient in infecting and replicating
in either moDC or bone marrow-derived DC (BMDC), although this infection did not result in any
morphological, phenotypical (MHC I, MHC II, CD80/86 expression), or functional modulation of
these cells [29]. In addition, CSFV did not interfere with DC maturation (using IFN-α and TNF-α)
or its ability to present antigen and stimulate T cell responses [29]. The virus was unable to induce
any cytokine response by these cells and it did not interfere with TNF-α or IL-6 induced by LPS
or poly(I:C), but affected IFN-α response to poly(I:C) stimulation [29]. These results suggested that
CSFV has developed mechanisms to prevent antiviral responses and to covertly replicate in DC [29].
The inhibition of IFN-α production by CSFV-cells was observed in other cell types and it is linked to
the blocking of IRF3 by the CSFV protein Npro [61,62]. The role of Npro on moDC modulation was
further investigated: Bauhofer et al. (2005) observed that Npro deleted mutants, but not wild-type
CSFV, induced maturation (CD80/86 upregulation) and type I IFN production by moDC. Npro deletion
did not influence the dsRNA levels during CSFV infection, which suggests that this protein regulates
type I IFN induction downstream of dsRNA detection [63]. In addition, it was reported that CSFV Npro
prevented type I IFN sensitisation of BMDC [64]. The role of nuclear factor kappa B (NF-κB) during
CSFV infection was also investigated [65]. NF-κB is a transcription factor, which plays a key role in
initiating the responses to pathogens [66]. CSFV infection did not result in p65/RelA translocation
from the cytoplasm to the nucleus and it did not alter the expression of p65/RelA and IkBα, which
indicates that NF-κB remained inactive during moDC infection [65]. These results suggested that CSFV
controlled the activation of this transcription factor, inhibiting its antiviral effect and thus evading the
host immune responses [65].
Several authors also assessed the interaction of CSFV with cDC and pDC. Jamin et al. (2008)
analysed the activation of both cDC (CD172a+CD11R1+) and pDC (CD172a+CD4+) at early time points
after CSFV infection [67]. Both subsets, in both blood and lymphoid organs, were susceptible to CSFV
infection, which resulted in their maturation and activation, as demonstrated by CD1a down-regulation,
CD80/86 upregulation, and cytokine expression [67]. cDC expressed TNF-α and IL-10, whereas, pDC
mainly expressed IFN-α and IL-12. The tonsils and blood pDC also expressed TNF-α. Pathologically
high levels of IFN-αwere detected in serum early post-infection, and CSFV-infected pDC were probably
the source [67]. A previous study reported that pDC release IFN-α after CSFV infection, with higher
responses by pDC from immunised when compared to naïve pigs [68]. CSFV Npro can block type I
IFN production by cDC more efficiently than pDC; IRF7, which is more prominent in pDC, is less
affected by this protein [69]. Nevertheless, CSFV Npro negatively regulates IRF7, probably through
interference with its turnover, reducing IFN-α release by pDC, not only after CSFV infection, but also in
response to other stimuli [69]. Moreover, it has been recently shown that interaction of CSFV-infected
cells with uninfected bystander pDC induces greater IFN-α production when compared to direct
infection of pDC [70]. Viral RNA transfer dependant on cell contact between pDC and infected cells;
intact cytoskeleton and lipid rafts of the donor cells were required for this effect. The ability to sense
virus-infected cells is advantageous for defence against viruses that are mainly cell-associated, like
pestiviruses. Interestingly, the RNase activity of CSFV Erns limited this pathway of pDC activation,
which represents a survival strategy for the virus [70]. Type I IFN release by CSFV-infected pDC was
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linked to the partial activation of NK and γδ-T cells [71]. We observed that pDC release high levels
of IFN-α in response to both virulent and attenuated CSFV strains, and this cytokine led to MHC II
up-regulation on NK and γδ-T cells. In addition, a similar NK/γδ-T cell phenotype was most strikingly
observed on cells that were isolated from tonsils and retropharyngeal lymph nodes during infection
with virulent CSFV. This effect inversely correlated with protection and it was not associated with
the ability of NK and γδ-T cells to release IFN-γ or to express perforin, which would instead have
been effective against CSFV [71]. We speculated that exacerbated type I IFN may compromise the
development of a protective cellular immune response through the induction of MHC-II up-regulation
on NK/γδ-T cells, thus impairing the professional DC-induced T cell responses in lymphoid tissues
due to competitive antigen-presentation [71]. The exacerbated pDC-mediated type I IFN response
against CSFV is likely to also be related to the induction of lymphocyte apoptosis, which further
antagonizes the development of a protective T cell response. It was observed that virulent CSFV
strains induced pathologically high levels of systemic IFN-α, which were detectable from two days
post-infection [72,73]. This type I IFN response was correlated to the virulence of the viral strain used,
with attenuated strains not inducing any detectable serum level of this cytokine. Lymphocyte depletion
during infection with virulent CSFV strains was attributed to induction of apoptosis in uninfected
bystander lymphocytes, where the up-regulation of apoptosis-related IFN stimulated genes (ISG)
was described [74,75]. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) released
by CSFV-infected cells might also cause CSFV induced lymphopenia [76]. It can be speculated that
the lower replication of live attenuated CSFV in target cells, like DC, might result in lower release of
IFN-α/TRAIL and other pro-apoptotic molecules when compared to virulent isolates, “buying time”
to develop a protective adaptive immune response. Figure 5 summarizes interactions of CSFV with
different DC subsets.
3.3. DC and PCV2
PCV2 is a small non-enveloped DNA virus linked with several syndromes, commonly known as
porcine circovirus–associated diseases (PCVAD), which compromises pork production by its effect
on piglet mortality, reproduction, and growth [1,77]. Infection with this virus can be subclinical or
associated with different pathological features, like PCV2 systemic disease (PCV2-SD), lung disease
(PCV2-LD), enteric disease (PCV2-EC), reproductive disease (PCV2-RD), and porcine dermatitis and
nephropathy syndrome (PDNS) [77]. How PCV2 causes such diseases is still largely unknown and a
combination of different elements (virus, host, and environment) likely determine whether the infection
results in subclinical disease or fatal outcome [78,79]. PCV2 is widespread worldwide in pig and wild
boar populations, with a high circulation rate [1,80]. PCV2 is a member of the genus Circovirus, within
the family Circoviridae, has a single-stranded circular genome of 1766–1768 nucleotides. During its
replication, a dsDNA intermediate is generated, which encodes genes in both the viral (ORF1, also called
Rep gene) and the complementary (ORF2, also called Cap gene, and ORF3) strands [79]. This virus
presents the highest genetic variability among single-stranded-DNA viruses and it is characterised by a
high rate of nucleotide substitution, being close to that of RNA viruses [81]. Currently four genotypes
(PCV2a, PCV2b, PCV2c, and PCV2d) have been identified [79].
This virus deeply affects the functionality of the pig immune system, with massive lymphoid
depletion being observed in PCV2-SD, whereas asymptomatic PCV2-infected pigs are able to mount
humoral and cellular immune responses, clearing or limiting the infection. Mechanisms beyond PCV2
immunopathogenesis are still poorly understood and many knowledge gaps need to be filled [78,79,82].
In addition, the available vaccines do not induce sterile immunity and PCV2 continues circulating in
farms applying vaccination [82]. A better comprehension on PCV2 interaction with the host immune
system is required to prevent and control PCVAD.
PCV2 interaction with DC was reviewed in 2009, 2010, and 2012 [78,83,84], and in this article
we will provide an update. In 2003, Vincent et al. observed that PCV2 infected BMDC and moDC
in vitro, without effects on their viability or the modulation of surface marker expression (MHC I,
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MHC II, CD80/86, CD14, CD16, CD25). However, the virus was unable to replicate in these cells,
even when they were co-cultured with syngeneic T cells, although PCV2 infectivity remained intact
throughout the experiment (five days) [85]. Steiner et al., (2008) observed that moDC were unable
to support PCV2 replication, despite their efficient ability in virus binding and uptake. On the
contrary, all of the other cell lines that were tested in the study (endothelial cell line PEDSV.15, aortic
endothelial cell, gut epithelial cell, fibrocyte) supported detectable virus replication [86]. PCV2 can
persist in DC in the absence of virus replication or degradation, thus it can be speculated that these
cells could serve as a vehicle for virus that is spread through the host [85,86]. Even if the virus did
not directly modulate moDC function, their function was impaired by co-culture with PCV-2 infected
porcine iliac endothelial cells (PIECs). PCV2-infected PIEC, but not the virus itself, inhibited moDC
maturation (assessed by MHC II and CD80/86 expression) and weakened their ability to stimulate
allogeneic T cells, which suggests that PCV2 infection of endothelial cells might represent a pathogenic
mechanism of this virus [87]. In contrast, Kekarainen et al. observed that PCV2 induced both IL-10
and IL-12 release by BMDC, and IL-12 secretion was triggered also by PCV2 virus-like particles [88,89].
In addition, PCV-2 inhibited IFN-α release by BMDC in response to PRV infection, and a similar
immunomodulatory effect was induced by PCV2-derived CpG sequences, which were mainly located
within the Rep gene [88,89]. Another study reported that moDC strongly responded to the PCV-2
infection, with increased expression of 40 genes, mainly immune-related and pro-apoptotic [90]. Using
both microarray and RT-PCR, the authors observed that PCV2 infection up-regulated TNF, PTGNES,
CXCL2, IL-8, IL-1β, and IL-1α, which might be related to the lymphocyte depletion and inflammation
observed in PCVAD [90]. Lin et al. studied which factors facilitated PCV2 replication in DC [91].
The virus was unable to replicate in either untreated or LPS-treated moDC, and LPS had no effects
on PCV2 antigen localization. On the contrary, moDC displayed an accessory function, increasing
cell proliferation and PCV2 replication in concanavalin A-stimulated PBMC. The latter effect required
direct contact between moDC and PBMC [91].
PCV2 was able to infect blood cDC and pDC in vitro, without affecting their expression of MHC II
and CD80/86. Interestingly, the virus compromised pDC cytokine responses to TLR-9 stimulation [92].
This pDC impairment was dependant on PCV2 DNA, but not viral replication [93]. In addition,
circular viral DNA had a stronger inhibitory effect when compared to linear viral DNA [94]. This pDC
inhibitory effect was not due to a reduction in CpG-ODN uptake, since PCV2-infected pDC efficiently
internalized this TLR-9 ligand. In addition, the virus inhibited pDC IFN-β release in response to
other stimuli: TLR-7 ligand (R837), TGEV, PRV, and CSFV [93]. This inability to activate pDC is in
accordance with the low type I IFN levels that were found in the sera of PCV2 infected pigs [95],
and this pDC impairment might also affect cDC maturation, with consequent impairment of the
development of immune defence against PCV2 and other pathogens [92,93]. In addition, a link between
PCV2 immunomodulatory capacity and cytoskeleton reorganization was observed: PCV2 viral DNA
impaired both pDC actin polymerization and moDC endocytosis, which suggests an effect of this
virus on DC danger recognition [93]. In 2013, Baumann et al. assessed which factors may increase
pDC type I response to PCV2 and observed that, in the presence of IFN-γ, but not IFN-β, Flt3-L,
GM-CSF, pDC were stimulated by this virus [96]. Interestingly, DNase treatment did not influence
PCV-2 IFN-α release by IFN-γ activated pDC, suggesting that this stimulatory effect was mediated by
the encapsulated viral ssDNA [96]. These results suggested a critical role of IFN-γ in sensing PCV2 by
the innate immune system.
In vivo, PCV2 antigen has been found in macrophages, DC, and follicular dendritic cells [97–99].
A recent study focused on moDC generated from blood monocytes of PCV-2 infected pigs [100].
It was observed that PCV2 infection in vivo impaired DC functions: at the peak of virus proliferation
(7 days post-infection), moDC generated from infected pigs presented reduced MHC II and CD80/86
expressions, lower levels of IL-10, IL-12, IL-8, MIP-1β, and reduced ability to stimulate T cells.
This DC dysfunction could be at least, in part, responsible for PCV2-induced immunosuppression [100].
Interactions of PCV2 with different DC subsets are summarized in Figure 5.
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4. Conclusions
In the first part of this review we provided an update on porcine DC family. We hope to have
conveyed the complexity of this system, which is composed of different subsets whose phenotype
is partially organ-specific. When considering both the importance of pork as a source of animal
protein for an expanding human population and the role of the pig as animal model in many fields of
biomedical research, more studies are needed to better characterise the functional roles of DC subsets
in this species. In the second part of this review, we summarized the main findings on three key
porcine viruses’ modulation of DC phenotype and functionality. These viruses differently modulate
DC functions: virulent ASFV and CSFV appear to have developed mechanisms to covertly replicate in
myeloid DC, whereas PCV2 was able to persist in DC in the absence of virus replication or degradation,
thus these viruses probably use these cells as a vehicle to spread through the host. PCV2 infection
impaired pDC function, on the contrary, both ASFV and CSFV stimulated pDC, and this might be
the source of the pathologically high type I IFN in animals undergoing these acute swine fevers.
These studies on virus-DC interaction mainly focused on moDC and blood DC, and very few papers
assessed virus interaction with skin, mucosal, tonsillar, or lymph node DC. In addition, differences in
responses to infection between cDC subsets, derived from blood or from different tissue sites, were not
investigated. We suggest that further studies in this area are needed, to better understand both diseases
pathogenesis and mechanisms behind protection. Better knowledge regarding the immunobiology
of porcine DC system and its interaction with pathogens will undoubtedly aid the rational design of
improved vaccines.
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